Skip to main content
TipRanks
Go Ultimate75% OFF

Top Page

TSEE

T. Rowe Price Small Cap ETF (TSEE)

Rating:60Neutral
Price Target:$26.00â–²(3.41% Upside)

TSEE, the T. Rowe Price Small Cap ETF, earns a solid overall rating driven by several financially strong and strategically well-positioned holdings like InterDigital, TMX Group, Repligen, Osisko Gold Royalties, PrairieSky Royalty, and BrightSpring Health Services, which contribute stable performance, growth, and positive sentiment despite some valuation concerns. The fund’s rating is held back somewhat by weaker names such as Dyne Therapeutics, Grocery Outlet, and Oscar Health, where profitability, cash flow, and bearish technical trends pose challenges. The main risk factor is exposure to multiple companies with high valuations or profitability pressures, which can make the ETF more sensitive to market volatility and earnings disappointments.

Positive Factors
Strong Top HoldingsSeveral of the largest positions, especially in health care and related names, have shown strong gains so far this year, helping support the ETF’s overall results.
Broad Sector DiversificationThe fund spreads its assets across many different sectors, which can help reduce the impact if any single industry runs into trouble.
Focused Small-Cap ExposureBy concentrating on smaller companies, the ETF offers investors targeted exposure to a part of the market that can provide higher growth potential over time.
Negative Factors
High U.S. ConcentrationMost of the portfolio is invested in U.S. stocks, which limits the diversification benefits from other regions and ties performance closely to the U.S. economy.
Elevated Expense RatioThe fund’s expense ratio is on the higher side for an ETF, which means more of the returns are used to cover fees instead of going to investors.
Mixed Performance Among Top HoldingsWhile several leading positions have performed well, at least one notable holding has been weak this year, which can drag on the fund’s overall performance.

TSEE vs. SPDR S&P 500 ETF (SPY)

-10%-5%0%5%10%15%20%SPY+14.55%TSEE-0.33%Oct '26Nov '26
AUM
10.70M
Region
North America
Expense Ratio
0.59%
Beta
0.39
Issuer
T. Rowe Price
Inception Date
Sep 17, 2026
Dividend Yield
N/A
Asset Class
Equity
Index Tracked
No Underlying Index

TSEE Summary

The T. Rowe Price Small Cap ETF (TSEE) is an actively managed fund that focuses on smaller U.S. companies, rather than tracking a set index. It spreads investments across many industries, including health care, financials, and industrials, with top holdings like Dyne Therapeutics and Grocery Outlet. Someone might invest in TSEE to seek long-term growth and diversify beyond large, well-known stocks by adding smaller, up-and-coming businesses. However, because it invests in small companies, the share price can be more volatile and may rise and fall more sharply than the overall market.

How much will it cost me?

This ETF has an expense ratio of 0.59%, which means you’ll pay about $5.90 per year for every $1,000 you invest. That’s higher than the average index ETF because this fund is actively managed, where professional managers research and select small-cap stocks rather than simply tracking a benchmark.

What would affect this ETF?

This ETF could benefit if the U.S. economy stays healthy, small-cap companies regain investor interest, and sectors like health care, financials, and industrials see steady growth or supportive regulations that help smaller businesses expand. On the other hand, rising interest rates, an economic slowdown in the U.S., or setbacks in health care and energy companies could hurt many of its holdings and make the fund more volatile than large-cap-focused investments.

TSEE Top 10 Holdings

TSEE leans heavily into U.S. small caps with a clear tilt toward health care and financial names, and a dash of Canadian exposure through TMX Group and PrairieSky Royalty. Oscar Health and BrightSpring Health Services have been rising sharply, helping power the fund’s recent momentum, while Repligen and InterDigital add steady, tech-leaning support after mixed stretches. On the other side, Dyne Therapeutics has been lagging, and Osisko Gold Royalties has lost some shine, modestly dragging on returns. Overall, a concentrated bet on smaller, more volatile growth stories.

TSEE top ten holdings
NameCompany NameWeight %Market ValueMarket CapYearly GainOverall Rating
LLYVKLLYVKLiberty Media Corp. Series C Liberty Live2.14%$230.80K$9.66B26.10%――
DYNDYNDyne Therapeutics1.89%$204.23K$3.22B-8.87%43Neutral
TMXXFTMXXFTMX Group――――70Outperform
GOGOGrocery Outlet Holding1.53%$164.95K$1.25B13.05%52Neutral
MIRMIRMirion Technologies1.47%$159.07K$4.36B-26.14%66Neutral
OSCROSCROscar Health1.40%$151.55K$9.58B122.58%49Neutral
IDCCIDCCInterDigital1.37%$148.02K$7.43B-16.55%76Outperform
OROROR Royalties――――70Outperform
PNFPPNFPPinnacle Financial Partners1.26%$136.11K$15.27B15.00%73Outperform
PLNTPLNTPlanet Fitness1.23%$133.17K$4.62B-42.88%70Outperform

TSEE Technical Analysis

Technical Analysis SentimentPositive
Last Price25.14

Price Trends

Market Momentum

MACD0.14Negative
RSI52.67Neutral
STOCH77.42Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TSEE, the sentiment is Positive. The current price of 25.14 is above the 20-day moving average (MA) of 24.87, compared to the 50-day MA of , and compared to the 200-day MA of , indicating a neutral trend. The MACD of 0.14 indicates Negative momentum. The RSI at 52.67 is Neutral, neither overbought nor oversold. The STOCH value of 77.42 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSEE.

TSEE Peer Comparison

Comparison Results

TSEE against its peer funds
NamePricePrice TargetAUMExpense RatioOverall Rating
TSEETSEE$25.14$26.00(3.41% Upside)$10.70M0.59%60Neutral
RUSCRUSC$36.71$50.48(37.52% Upside)$84.23M0.64%64Neutral
AIMSAIMS$26.69$33.96(27.24% Upside)$82.55M0.75%65Neutral
SYZSYZ$29.03$37.03(27.57% Upside)$60.09M0.61%66Neutral
ESSCESSC$28.58$37.99(32.94% Upside)$33.51M0.49%66Neutral
FTKIFTKI$19.70$24.31(23.39% Upside)$25.59M0.86%64Neutral

Performance Comparison

0%10%20%30%TSEERUSCAIMSSYZESSCFTKIOct '26Nov '26
TSEE and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TSEET. Rowe Price Small Cap ETF25.14-0.08-0.33%
RUSCUS Small Cap Equity Active ETF36.717.5125.71%
AIMSAcuitas Small Cap Active ETF26.681.505.98%
SYZLazard US Systematic Small Cap Equity ETF29.025.4823.30%
ESSCEventide Small Cap ETF28.584.5418.90%
FTKIFirst Trust Small Cap BuyWrite Income ETF19.703.1719.16%
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.